Heart valve replacement surgery has a high success rate, with roughly 85% of patients surviving at least five years after the procedure. Short-term operative mortality ranges from about 2% to 7% depending on the valve being replaced, the surgical approach, and the patient’s overall health. These numbers have improved steadily over the past few decades, and survival across all major procedure types continues to trend upward.
Five-Year Survival by Procedure Type
For aortic valve replacement, the most common type, five-year survival in low-risk patients is around 85% to 87% regardless of whether the surgery is done through open-heart surgery or a catheter-based approach (TAVR). A large trial published in the Journal of the American College of Cardiology found that all-cause mortality at five years was 14.7% for TAVR patients and 15.2% for surgical patients, a difference that was not statistically meaningful. In other words, both methods produce similar survival results in patients who are otherwise relatively healthy.
For patients at low to intermediate surgical risk, a separate analysis in BMJ’s Heart journal found slightly higher five-year mortality: 29.7% for TAVR and 27.6% for open surgery. This group included sicker patients overall, which explains the gap. That analysis also found a high probability that traditional open-heart surgery edges out TAVR over five years in this broader population, particularly when stroke risk is factored in.
Mitral valve replacement carries somewhat different numbers. A large matched study from Emory University tracking patients over a decade found 10-year survival of 46% for mitral valve replacement. Age matters enormously here: patients under 60 had 55% survival at 10 years, while those 60 and older had 36%. In-hospital mortality for mitral valve replacement was about 6.9%.
Repair vs. Replacement for the Mitral Valve
When surgeons can repair a mitral valve instead of replacing it entirely, outcomes improve significantly. In-hospital mortality drops from about 6.9% to 4.3%, and 10-year survival jumps from 46% to 62%. The benefit is especially dramatic in younger patients: those under 60 who had repair surgery had 81% survival at 10 years compared to 55% for those who received a replacement.
Repair patients also spend less time in the hospital, averaging about 9.5 days compared to 12.3 days for replacement. Not every valve can be repaired, but when the anatomy allows it, repair is generally the preferred option.
Mechanical vs. Biological Valves
When replacement is necessary, the choice between a mechanical valve and a biological (tissue) valve affects long-term durability. The core tradeoff: mechanical valves almost never fail structurally, but they require lifelong blood-thinning medication. Biological valves don’t require blood thinners long-term, but they wear out over time.
A Veterans Affairs trial tracking patients for 15 years found that primary valve failure for aortic replacements was essentially 0% with mechanical valves compared to 23% with biological valves. For mitral replacements, the gap was even wider: 5% mechanical failure versus 44% biological failure. Reoperation rates followed a similar pattern. After aortic replacement, 10% of mechanical valve patients needed a second surgery at 15 years compared to 29% of biological valve patients.
Age plays a critical role in this decision. In patients under 65, biological valves failed at dramatically higher rates: 26% for aortic and 44% for mitral positions. But in patients 65 and older, the failure rate of biological aortic valves dropped to about 9%, which was not statistically different from mechanical valves. This is why surgeons typically recommend biological valves for older patients and mechanical valves for younger ones. A biological valve may last 15 to 20 years, which is often sufficient for someone in their 70s, while a 50-year-old would likely need at least one additional surgery.
TAVR vs. Open-Heart Surgery
TAVR (transcatheter aortic valve replacement) involves threading a new valve through a blood vessel, usually in the groin, rather than opening the chest. It was originally developed for patients too frail for open surgery, but trials have now extended it to low-risk patients as well.
At five years, survival rates between TAVR and open surgery are similar in low-risk patients, with mortality hovering around 13% to 15% for both groups. However, the broader evidence suggests open surgery may hold a small edge over time. A pooled analysis found a 99.5% probability that open surgery produces better combined outcomes for death and stroke at five years in low-to-intermediate risk patients. The stroke rate specifically trended higher with TAVR, though the difference was not conclusive on its own.
The practical advantage of TAVR is recovery. Patients typically leave the hospital within one to three days instead of a week or more, and they return to normal activity much faster. For older patients or those with other health conditions that make open-chest surgery risky, TAVR can be the safer overall choice even if the valve itself may not last quite as long.
Factors That Influence Your Individual Risk
The numbers above are averages, and individual outcomes vary widely based on several factors. The Emory study identified the strongest predictors of long-term mortality after valve surgery: increasing age, heart failure, reduced heart pumping function, diabetes, urgent or emergency operations, and needing bypass surgery at the same time as valve work. Patients who had valve replacement alongside coronary artery bypass had 10-year survival of only about 34%, compared to 51% for those who had valve replacement alone.
Your surgeon will calculate a personalized risk score before surgery, typically using the STS (Society of Thoracic Surgeons) risk model. This score accounts for your age, kidney function, lung disease, prior surgeries, and other conditions to estimate your specific operative risk. An STS score under 4% is considered low risk, and most patients in this category do very well.
What Recovery Looks Like
After open-heart valve surgery, recovery typically takes four to eight weeks, with some people needing longer. During the first few weeks, you’ll have lifting restrictions and won’t be able to drive. Your surgical team will clear you for activity milestones individually, including when you can return to walking, exercise, and work. Most people notice an improvement in symptoms like breathlessness and fatigue within weeks of surgery, though full stamina can take several months to return.
TAVR recovery is considerably faster. Many patients are walking the same day and back to light activities within a week or two. Hospital stays are typically one to three days rather than five to ten.
Regardless of the approach, you’ll need regular follow-up appointments to monitor how your new valve is functioning. Biological valves require periodic imaging to check for wear, especially after the 10-year mark. Mechanical valve patients need regular blood tests to ensure their blood-thinning medication stays in the right range.